Accelerate in Digital Health

ANDHealth+ assists digital health companies navigate the commercialisation pathway to institutional investment and international market entry. We work with mid-stage companies with evidence-based products focused on changing clinical outcomes. The program requires no equity consideration and is customised to each cohort company’s needs.

5 Projects Each Round

Eligibility: Mid-stage evidence based digital health technologies which have achieved proof-of-principle and have completed the ANDHealth Masterclass.

ANDHealth+ Provides

ANDHealth provides 6-9 months of bespoke advisory support and coaching from proven mentors, alongside access to funds for specific third party advice, to progress the technology towards investment. Companies selected for ANDHealth+ receive over $250k of services and support throughout the program.

ANDHealth+ Advantage

ANDHealth+ is Australia’s leading commercialisation program for connected and digital health companies. We do not take equity in our participant companies, and retain no rights to project IP.


Sign up to our mailing list to keep up to date with ANDHealth